ATHIRA PHARMA, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • August 9th, 2024 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledAugust 9th, 2024 Company Industry JurisdictionThis Change in Control and Severance Agreement (the “Agreement”) is made by and between Athira Pharma, Inc., a Delaware corporation (the “Company”), and Javier San Martin (“Executive”), effective as of April 15, 2024 (the “Effective Date”).